Lawson E Whiting sold $274k of BF-B
President & CEO at BROWN FORMAN CORP. 8,834 shares at an average of $31.00, traded Dec 12, 2025, filed Dec 16, 2025.
Score components
- +25RoleCEO
- +13Trade size$274k at market
- +5Share of holdings soldSold 21% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -9.8%, 3m -23.2%, 6m -10.9%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001572783-25-000009, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 12, 2025 | SOpen-market sale Class A Common10b5-1 | -8,834 | $31.00 | $274k | 32,933 | Dec 16, 2025 |
Related signals
Other insiders at BROWN FORMAN CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 47Moderate | BROWN FORMAN CORP | Lawson E Whiting President & CEO | $804k 25,915 shares | -79% | |
| 31Weak | BROWN FORMAN CORP | Lawson E Whiting President & CEO | $389k 12,531 shares | -25% | |
| 46Moderate | BROWN FORMAN CORP | Lawson E Whiting President & CEO | $733k 23,641 shares | -83% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.